2.0P461030UPDATE_2_0_163 INFLUENZA UPDATEMONTGOMERY,ALANSALT LAKE CITYNATREM^NATREM^ISC5A3^NATREM:DEV5A308/19/2020@11:23:04TIU TEMPLATE FIELD8927.1IM INFLUENZA VACCINE CONTRA WARNING170823888657118NOTIU TEMPLATE FIELD8927.1IM INFLUENZA CONTRAINDICATIONS169153154265495NOTIU TEMPLATE FIELD8927.1NCP INFLUENZA IMMUNIZATION GUIDANCE170324294259170NOIMMUNIZATION9999999.14INFLUENZA, HIGH DOSE SEASONAL6120132176663276NOIMMUNIZATION9999999.14INFLUENZA, HIGH-DOSE, QUADRIVALENT184775058253NOIMMUNIZATION9999999.14INFLUENZA, INJECTABLE, MDCK, QUADRIVALENT18431623976688NOIMMUNIZATION9999999.14INFLUENZA, RECOMBINANT, QUADRIVALENT,INJECTABLE, PRESERVATIVE FREE18421981809104NOIMMUNIZATION9999999.14INFLUENZA, INJECTABLE, MDCK, PRESERVATIVE FREE, QUADRIVALENT18308200942NOIMMUNIZATION9999999.14INFLUENZA, TRIVALENT, ADJUVANTED18272917702402NOIMMUNIZATION9999999.14INFLUENZA, INTRADERMAL, QUADRIVALENT, PRESERVATIVE FREE18053349694417NOIMMUNIZATION9999999.14INFLUENZA, INJECTABLE, QUADRIVALENT11582692752723NOIMMUNIZATION9999999.14INFLUENZA, RECOMBINANT, INJECTABLE, PRESERVATIVE FREE11553245845348NOIMMUNIZATION9999999.14INFLUENZA, INJECTABLE, MDCK, PRESERVATIVE FREE11533477280582NOIMMUNIZATION9999999.14INFLUENZA NASAL, UNSPECIFIED FORMULATION11511457862963NOIMMUNIZATION9999999.14INFLUENZA, INJECTABLE, QUADRIVALENT, PRESERVATIVE FREE11501598437239NOIMMUNIZATION9999999.14INFLUENZA, LIVE, INTRANASAL, QUADRIVALENT11492420478512NOIMMUNIZATION9999999.14INFLUENZA, SEASONAL, INTRADERMAL, PRESERVATIVE FREE11441560991064NOIMMUNIZATION9999999.14INFLUENZA, SEASONAL, INJECTABLE1141936454550NOIMMUNIZATION9999999.14INFLUENZA, SEASONAL, INJECTABLE, PRESERVATIVE FREE1140549383018NOIMMUNIZATION9999999.14INFLUENZA, LIVE, INTRANASAL542763216001NOIMMUNIZATION9999999.14INFLUENZA, UNSPECIFIED FORMULATION521488451854NOHEALTH FACTORS9999999.64VA-REMINDER UPDATES87221778499465NOHEALTH FACTORS9999999.64VA-UPDATE_2_0_163182091344883085NOHEALTH FACTORS9999999.64IMMUNIZATION6120432844738685NOHEALTH FACTORS9999999.64VA-INFLUENZA IMM PRECAUTION153802628816342NOHEALTH FACTORS9999999.64VA-INFLUENZA IMM CONTRAINDICATION150413634770667NOHEALTH FACTORS9999999.64VA-INFLUENZA IMM REFUSED150401263612875NOREMINDER SPONSOR811.6VA National Center for Health Promotion and Disease Prevention (NCP)31689859022NOREMINDER TERM811.5VA-REMINDER UPDATE_2_0_16316653667822481YESREMINDER TERM811.5VA-INFLUENZA IMM SEASONAL VACCINE FORMULATIONS14812279587681YESREMINDER DIALOG801.41PXRM COMMENT13865933290NOREMINDER DIALOG801.41VA-INFLUENZA VACCINE PRECAUTION OTHER294071529602244NOREMINDER DIALOG801.41VA-INFLUENZA VACCINE PRECAUTION ACUTE ILLNESS294062517297176NOREMINDER DIALOG801.41VA-GP TEXT INFLUENZA VACCINE PRECAUTION294051383098551NOREMINDER DIALOG801.41VA-GP INFLUENZA VACCINE PRECAUTION294041608664035NOREMINDER DIALOG801.41VA-TEXT INFLUENZA VACCINE CONTRAINDICATION WARNING2939919747018NOREMINDER DIALOG801.41VA-INFLUENZA VACCINE ALLERGY PRIOR DOSE294031724567382NOREMINDER DIALOG801.41VA-INFLUENZA VACCINE ALLERY COMPONENT294001077612269NOREMINDER DIALOG801.41VA-GP TEXT INFLUENZA CONTRAINDICATION29398465218530NOREMINDER DIALOG801.41VA-GP INFLUENZA CONTRAINDICATION PARENT293951622544452NOREMINDER DIALOG801.41VA-HF REFUSED INFLUENZA VACCINE29394923612476NOREMINDER DIALOG801.41VA-GP IM INFLUENZA DEFERRAL REFUSAL293932593831322YESREMINDER DIALOG801.41VAL-FLU IMM DETAILED INFO287661039938081YES
=65 years, any age-appropriate IIV formulation (standard
dose or high dose, trivalent or quadrivalent, unadjuvanted or adjuvanted)
or RIV4 are acceptable options.
{FLD:NCP INFLUENZA IMMUNIZATION GUIDANCE}
2020-2021 Influenza vaccine formulations on VA Formulary
Product Type CVX CPT
VistA Name Approved for age
Fluarix Quadrivalent 0.5mL Prefill Tip-Lok Syr IIV4 150 90686
INFLUENZA, INJECTABLE, QUADRIVALENT, PRESERV FREE >=6 months
Fluzone Quadrivalent Multiple-Dose Vial IIV4 158 90688
INFLUENZA, INJECTABLE, QUADRIVALENT >=6 months
Fluzone Quadrivalent High Dose Prefilled Syringe IIV4 197 90662
INFLUENZA, HIGH-DOSE, QUADRIVALENT >=65 years
CONTRAINDICATIONS: A previous severe allergic reaction to any component
of the influenza vaccine, or after a previous dose of any influenza
vaccine. Manufacturer package inserts and updated CDC/ACIP guidance
should be consulted for information on contraindications and precautions
for individual influenza vaccine products.\\
{FLD:IM INFLUENZA CONTRAINDICATIONS}
PRECAUTIONS: Vaccination of persons with moderate or severe acute
illness (with or without fever) is a general precaution for vaccination
and should generally be deferred until the acute illness has improved or
resolved. A history of GBS within 6 weeks after receipt of a previous
dose of influenza vaccine is considered a precaution for the use of
influenza vaccines.
EGG ALLERGY: Persons who report having had reactions to egg involving
symptoms other than urticaria (hives), such as angioedema, respiratory
distress, lightheadedness, or recurrent emesis; or who required
epinephrine or another emergency medical intervention, may similarly
receive any licensed, recommended, and age-appropriate influenza vaccine
(i.e., any IIV, RIV4, or LAIV4) that is otherwise appropriate for their
health status. The selected vaccine should be administered in an
inpatient or outpatient medical setting (including, but not necessarily
limited to, hospitals, clinics, health departments, and physician
offices). Vaccine administration should be supervised by a health care
provider who is able to recognize and manage severe allergic reactions.
801.41;+28766,;51~SUPPRESS
801.41;+28766,;100~LOCAL
801.44;+28767,+28766,;.01~08/19/2020@11:23:25
801.44;+28767,+28766,;2~WP-start~1
Exchange Stub
]]>
435035268063541079384120120111133133124146146137159159150172172163185185176198198189211211202224224215237237228250250241263263254276276267289289280302302293315315306328328319341341332355354345371368359386384375402399390418415406434431422451447438456456476469460482481522495486545527565558549570570598583574604603627617608632632661645636668666700681672706705729719710734734760747738766765792779770798797826811802833831867846837874872902887878908907941921912949946102196295310261026